{"id":"W3092112220","doi":"10.1016/j.jchf.2020.08.008","title":"N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes","year":2020,"lang":"en","type":"article","venue":"JACC Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Roche Diagnostics; Merck Sharp and Dohme; Servier; National Medical Research Council; Cytokinetics; Boston Scientific Corporation; Amgen; Boehringer Ingelheim; Medtronic; Roche; Novartis; Bayer; AstraZeneca; American Regent; Meso Scale Diagnostics; Sanofi; Merck; Vifor Pharma; Bristol-Myers Squibb Foundation","keywords":"Natriuretic peptide; Medicine; Heart failure; Hazard ratio; Internal medicine; Ejection fraction; Quartile; Clinical endpoint; Randomization; Confidence interval; Placebo; Cardiology; Clinical trial; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002407812,0.000239189,0.000589469,0.00006290524,0.0000868373,0.00004513445,0.0000678774,0.0001574202,0.0004011767],"category_scores_gemma":[0.0003295882,0.0001804692,0.000201563,0.0002107415,0.00009672617,0.000103235,0.0001112001,0.0003623691,0.0006508557],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002662672,"about_ca_system_score_gemma":0.0001044729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002136625,"about_ca_topic_score_gemma":0.00002456211,"domain_scores_codex":[0.9983764,0.0000781217,0.0004219967,0.000470732,0.0003085449,0.0003442095],"domain_scores_gemma":[0.9989314,0.0001180336,0.00005041044,0.0002810865,0.00007850705,0.0005405247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00014627,0.0001492645,0.660848,0.0001271306,0.0001729222,0.0002953872,0.0001740514,1.886057e-7,0.0001078598,0.0001501419,0.3360231,0.001805633],"study_design_scores_gemma":[0.00206308,0.001117594,0.228464,0.00004605573,0.0002731594,0.00009879809,0.000145591,0.00009445351,0.00003854883,0.00002218918,0.7674667,0.000169797],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6528463,0.000159057,0.00003502566,0.3445124,0.0001900919,0.001112962,0.000003693342,0.0002362896,0.0009041648],"genre_scores_gemma":[0.9590607,0.00005266581,0.0238652,0.01303827,0.0005674487,0.00002179015,0.00002622456,0.00004119753,0.003326548],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.432384,"threshold_uncertainty_score":0.8365651,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04419804845653504,"score_gpt":0.3421884006872881,"score_spread":0.2979903522307531,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}